313 related articles for article (PubMed ID: 16970255)
1. Epstein-Barr viral infection in renal allograft recipients: a single center experience.
Zadeh ZR; Makhdumi K; Lak SS
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):351-4. PubMed ID: 16970255
[TBL] [Abstract][Full Text] [Related]
2. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
Ahya VN; Douglas LP; Andreadis C; Arnoldi S; Svoboda J; Kotloff RM; Hadjiliadis D; Sager JS; Woo YJ; Pochettino A; Schuster SJ; Stadtmauer EA; Tsai DE
J Heart Lung Transplant; 2007 Aug; 26(8):839-44. PubMed ID: 17692789
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus in pediatric patients after renal transplantation.
Schwab M; Böswald M; Korn K; Ruder H
Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
[TBL] [Abstract][Full Text] [Related]
5. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
Saghafi H; Qorashi M; Heidari A
Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
Bakker NA; Verschuuren EA; Erasmus ME; Hepkema BG; Veeger NJ; Kallenberg CG; van der Bij W
Transplantation; 2007 Feb; 83(4):433-8. PubMed ID: 17318076
[TBL] [Abstract][Full Text] [Related]
7. Incidence of reactive antibodies against epstein-barr in a group of renal transplant patients.
Geramizadeh B; Aghdai M; Azarpira N; Behabahani AB; Heidari T; Banihashemi M; Raisjalali AR; Roozbeh J; Behzadi A
Transplant Proc; 2005 Sep; 37(7):3051-2. PubMed ID: 16213301
[TBL] [Abstract][Full Text] [Related]
8. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
[TBL] [Abstract][Full Text] [Related]
9. [Variability in Epstein-Barr virus serological markers in adult kidney transplant recipients].
Lauzurica R; Frías C; Bayés B; Ausina V; Romero R
Nefrologia; 2005; 25(2):185-90. PubMed ID: 15912656
[TBL] [Abstract][Full Text] [Related]
10. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
11. The effect of Epstein-Barr virus infection on medium-term survival after orthotopic heart transplantation.
Zakliczyński M; Krynicka-Mazurek A; Pyka Ł; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
Transplant Proc; 2007 Nov; 39(9):2862-5. PubMed ID: 18022003
[TBL] [Abstract][Full Text] [Related]
12. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
Verschuuren E; van der Bij W; de Boer W; Timens W; Middeldorp J; The TH
J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416
[TBL] [Abstract][Full Text] [Related]
14. Time course and frequency of Epstein-Barr virus reactivation after kidney transplantation: linkage to renal allograft rejection.
Jabs WJ; Maurmann S; Wagner HJ; Müller-Steinhardt M; Steinhoff J; Fricke L
J Infect Dis; 2004 Nov; 190(9):1600-4. PubMed ID: 15478064
[TBL] [Abstract][Full Text] [Related]
15. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
Babel N; Gabdrakhmanova L; Hammer M; Rosenberger C; Oppert M; Volk HD; Reinke P
Transpl Infect Dis; 2005; 7(3-4):133-6. PubMed ID: 16390402
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting reactivation of Epstein-Barr virus infection after kidney allograft transplantation.
Khameneh ZR; Soin J; Durlik M; Lao M; Paczek L; Gaciong Z
Ann Transplant; 1999; 4(2):18-22. PubMed ID: 10850586
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
[TBL] [Abstract][Full Text] [Related]
18. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation.
Engelmann I; Welte T; Fühner T; Simon AR; Mattner F; Hoy L; Schulz TF; Gottlieb J
J Clin Virol; 2009 May; 45(1):47-53. PubMed ID: 19303808
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
[TBL] [Abstract][Full Text] [Related]
20. Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring.
Tedeschi R; Bloigu A; Ogmundsdottir HM; Marus A; Dillner J; dePaoli P; Gudnadottir M; Koskela P; Pukkala E; Lehtinen T; Lehtinen M
Am J Epidemiol; 2007 Jan; 165(2):134-7. PubMed ID: 17005627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
